Skip to content
10-Q

Quarterly Report

ARCTURUS THERAPEUTICS HOLDINGS INC. ARCT

0001193125-25-275758

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 28.41M sh
Shares Diluted Q3 2025 · Sep 30, 2025 27.19M sh
Shares Diluted Q3 2025 · Sep 30, 2025 27.14M sh
Shares Diluted Q3 2025 · Sep 30, 2024 27.06M sh
Shares Diluted Q3 2025 · Sep 30, 2024 26.97M sh
Capex Q3 2025 · Sep 30, 2025 $318K
Capex Q3 2025 · Sep 30, 2024 $648K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$58.04M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$59.46M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $180.36M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $237.03M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $237.18M
Stockholders Equity Q3 2025 · Sep 30, 2025 $224.56M
Stockholders Equity Q3 2025 · Jun 30, 2025 $231.05M
Stockholders Equity Q3 2025 · Mar 31, 2025 $233.76M
Stockholders Equity Q3 2025 · Dec 31, 2024 $240.98M
Stockholders Equity Q3 2025 · Sep 30, 2024 $261.87M
Stockholders Equity Q3 2025 · Jun 30, 2024 $258.58M
Stockholders Equity Q3 2025 · Mar 31, 2024 $263.97M
Stockholders Equity Q3 2025 · Dec 31, 2023 $278.51M
Current Liabilities Q3 2025 · Sep 30, 2025 $31.7M
Current Liabilities Q3 2025 · Dec 31, 2024 $65.49M
Total Liabilities Q3 2025 · Sep 30, 2025 $57.78M
Total Liabilities Q3 2025 · Dec 31, 2024 $103.09M
Current Assets Q3 2025 · Sep 30, 2025 $249.2M
Current Assets Q3 2025 · Dec 31, 2024 $305.98M
Total Assets Q3 2025 · Sep 30, 2025 $282.34M
Total Assets Q3 2025 · Dec 31, 2024 $344.07M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.49
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.35
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.26
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.89
Eps Basic Q3 2025 · Sep 30, 2025 −$0.49
Eps Basic Q3 2025 · Sep 30, 2025 −$1.35
Eps Basic Q3 2025 · Sep 30, 2024 −$0.26
Eps Basic Q3 2025 · Sep 30, 2024 −$1.89
Sga Expense Q3 2025 · Sep 30, 2025 $10.4M
Sga Expense Q3 2025 · Sep 30, 2025 $32.05M
Sga Expense Q3 2025 · Sep 30, 2024 $13.28M
Sga Expense Q3 2025 · Sep 30, 2024 $40.44M
Rd Expense Q3 2025 · Sep 30, 2025 $23.27M
Rd Expense Q3 2025 · Sep 30, 2025 $87.74M
Rd Expense Q3 2025 · Sep 30, 2024 $39.13M
Rd Expense Q3 2025 · Sep 30, 2024 $151.38M
Net Income Q3 2025 · Sep 30, 2025 −$13.45M
Net Income Q3 2025 · Sep 30, 2025 −$36.7M
Net Income Q3 2025 · Jun 30, 2025 −$9.18M
Net Income Q3 2025 · Mar 31, 2025 −$14.08M
Net Income Q3 2025 · Sep 30, 2024 −$6.9M
Net Income Q3 2025 · Sep 30, 2024 −$50.94M
Net Income Q3 2025 · Jun 30, 2024 −$17.22M
Net Income Q3 2025 · Mar 31, 2024 −$26.82M
Operating Income Q3 2025 · Sep 30, 2025 −$16.51M
Operating Income Q3 2025 · Sep 30, 2025 −$44.95M
Operating Income Q3 2025 · Sep 30, 2024 −$10.74M
Operating Income Q3 2025 · Sep 30, 2024 −$62.28M
Revenue Q3 2025 · Sep 30, 2025 $17.15M
Revenue Q3 2025 · Sep 30, 2025 $74.84M
Revenue Q3 2025 · Sep 30, 2024 $41.67M
Revenue Q3 2025 · Sep 30, 2024 $129.54M